313 related articles for article (PubMed ID: 19409634)
1. Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment.
Phan JH; Moffitt RA; Stokes TH; Liu J; Young AN; Nie S; Wang MD
Trends Biotechnol; 2009 Jun; 27(6):350-8. PubMed ID: 19409634
[TBL] [Abstract][Full Text] [Related]
2. Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression.
Cooley LS; Rudewicz J; Souleyreau W; Emanuelli A; Alvarez-Arenas A; Clarke K; Falciani F; Dufies M; Lambrechts D; Modave E; Chalopin-Fillot D; Pineau R; Ambrosetti D; Bernhard JC; Ravaud A; Négrier S; Ferrero JM; Pagès G; Benzekry S; Nikolski M; Bikfalvi A
Mol Cancer; 2021 Oct; 20(1):136. PubMed ID: 34670568
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomics in RCC.
Syed JS; Brito J; Pooli A; Boutros PC; Shuch B
Urol Oncol; 2020 Oct; 38(10):742-754. PubMed ID: 32222350
[TBL] [Abstract][Full Text] [Related]
4. Current and Future Biomarkers in the Management of Renal Cell Carcinoma.
Reese S; Calderon L; Khaleel S; Hakimi AA
Urol Clin North Am; 2023 Feb; 50(1):151-159. PubMed ID: 36424079
[TBL] [Abstract][Full Text] [Related]
5. [Renal cell cancer].
Németh I; Iványi B; Pajor L
Orv Hetil; 2006 Jul; 147(28):1336-7. PubMed ID: 16999021
[No Abstract] [Full Text] [Related]
6. Nanotechnology for targeted cancer therapy.
Wang MD; Shin DM; Simons JW; Nie S
Expert Rev Anticancer Ther; 2007 Jun; 7(6):833-7. PubMed ID: 17555393
[TBL] [Abstract][Full Text] [Related]
7. The promise of biomarkers for personalized renal cancer care.
Devarajan P
Kidney Int; 2010 May; 77(9):755-7. PubMed ID: 20393489
[TBL] [Abstract][Full Text] [Related]
8. Genomics and proteomics in renal cell carcinoma: diagnosis, prognosis, and treatment selection.
Jones J; Pantuck AJ
Curr Urol Rep; 2008 Jan; 9(1):9-14. PubMed ID: 18366968
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology in cancer diagnosis: progress, challenges and opportunities.
Zhang Y; Li M; Gao X; Chen Y; Liu T
J Hematol Oncol; 2019 Dec; 12(1):137. PubMed ID: 31847897
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.
Osunkoya AO; Yin-Goen Q; Phan JH; Moffitt RA; Stokes TH; Wang MD; Young AN
Hum Pathol; 2009 Dec; 40(12):1671-8. PubMed ID: 19695674
[TBL] [Abstract][Full Text] [Related]
11. Personalized Management of Advanced Kidney Cancer.
Graham J; Heng DYC; Brugarolas J; Vaishampayan U
Am Soc Clin Oncol Educ Book; 2018 May; 38():330-341. PubMed ID: 30231375
[TBL] [Abstract][Full Text] [Related]
12. [Research advancement and prospects of nanotechnology in early diagnosis and treatment of cancer].
Hu DH; Gong P; Ma YF; Cai LT
Ai Zheng; 2009 Sep; 28(9):1000-3. PubMed ID: 19728922
[TBL] [Abstract][Full Text] [Related]
13. [Personalised medicine in renal cell tumours].
Junker K; Zeuschner P
Aktuelle Urol; 2019 Sep; 50(5):513-523. PubMed ID: 31167243
[TBL] [Abstract][Full Text] [Related]
14. Research progress on advanced renal cell carcinoma.
Song XD; Tian YN; Li H; Liu B; Zhang AL; Hong Y
J Int Med Res; 2020 Jun; 48(6):300060520924265. PubMed ID: 32529862
[TBL] [Abstract][Full Text] [Related]
15. Predictive biomarker candidates to delineate efficacy of antiangiogenic treatment in renal cell carcinoma.
Romero-Laorden N; Doger B; Hernandez M; Hernandez C; Rodriguez-Moreno JF; Garcia-Donas J
Clin Transl Oncol; 2016 Jan; 18(1):1-8. PubMed ID: 26169213
[TBL] [Abstract][Full Text] [Related]
16. Update on Biomarkers in Renal Cell Carcinoma.
Saliby RM; Saad E; Kashima S; Schoenfeld DA; Braun DA
Am Soc Clin Oncol Educ Book; 2024 Jan; 44(2):e430734. PubMed ID: 38207251
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomic biomarkers for personalized cancer treatment.
Rodríguez-Antona C; Taron M
J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
[TBL] [Abstract][Full Text] [Related]
18. Genitourinary imaging: part 2, role of imaging in medical management of advanced renal cell carcinoma.
Shinagare AB; Krajewski KM; Jagannathan JP; Ramaiya NH
AJR Am J Roentgenol; 2012 Nov; 199(5):W554-64. PubMed ID: 23096199
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of Renal Tumors: the Current State and Clinical Perspectives.
Golovastova MO; Korolev DO; Tsoy LV; Varshavsky VA; Xu WH; Vinarov AZ; Zernii EY; Philippov PP; Zamyatnin AA
Curr Urol Rep; 2017 Jan; 18(1):3. PubMed ID: 28110463
[TBL] [Abstract][Full Text] [Related]
20. Selecting clinically-driven biomarkers for cancer nanotechnology.
Phan JH; Young AN; Wang MD
Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():3317-20. PubMed ID: 17947020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
